Trademark: 88122086
Status Date
Thursday, April 13, 2023
Registration Number
5930040
Registration Date
Tuesday, December 10, 2019
Filing Date
Tuesday, September 18, 2018
Published for Opposition
Tuesday, September 24, 2019
Cancellation Date
Thursday, April 13, 2023
5 Prescribed pharmaceuticals as live biotherapeutics for the treatment of cancer, central nervous system diseases, and gastrointestinal diseases; live biotherapeutic pharmaceuticals for the treatment of inflammatory and autoimmune diseases; pharmaceuticals, namely, live biotherapeutic bacterial formulations for medical use for the treatment of cancer, central nervous system diseases, gastrointestinal diseases, and inflammatory and autoimmune diseases; lyophilized formulations of microorganisms for medical use
In the statement, lines 2 and 3 should be deleted and 9 Bond Court should be inserted; and in line 4 "Aberdeen" should be deleted and Leeds should be inserted and "AB252ZS" should be deleted and LS1 2JZ should be inserted.
Apr 13, 2023
Cancelled Section 18-Total
Apr 13, 2023
Cancellation Terminated No. 999999
Apr 12, 2023
Cancellation Granted No. 999999
Jan 12, 2023
Cancellation Instituted No. 999999
Aug 20, 2021
Sec 7 Request Filed
Aug 27, 2021
Correction Under Section 7 ¿ Processed
Aug 27, 2021
Assigned To Paralegal
Aug 20, 2021
Teas Section 7 Request Received
Jun 2, 2021
Automatic Update Of Assignment Of Ownership
Dec 10, 2019
Registered-Principal Register
Sep 24, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 24, 2019
Published For Opposition
Sep 4, 2019
Notification Of Notice Of Publication E-Mailed
Aug 16, 2019
Approved For Pub - Principal Register
Jul 26, 2019
Teas/Email Correspondence Entered
Jul 26, 2019
Correspondence Received In Law Office
Jul 24, 2019
Teas Response To Office Action Received
Jul 13, 2019
Notification Of Non-Final Action E-Mailed
Jul 13, 2019
Non-Final Action E-Mailed
Jul 13, 2019
Non-Final Action Written
Jun 22, 2019
Teas/Email Correspondence Entered
Jun 22, 2019
Correspondence Received In Law Office
Jun 22, 2019
Assigned To Lie
Jun 18, 2019
Teas Response To Office Action Received
Jan 7, 2019
Notification Of Non-Final Action E-Mailed
Jan 7, 2019
Non-Final Action E-Mailed
Jan 7, 2019
Non-Final Action Written
Dec 29, 2018
Assigned To Examiner
Sep 24, 2018
New Application Office Supplied Data Entered
Sep 21, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
